TIOTROPIUM inhaler (Spiriva® Respimat®) in adults with asthma - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

TIOTROPIUM inhaler (Spiriva® Respimat®) in adults with asthma

Last Updated: 01 November 2018

Body System: Respiratory system

Green

The Pan Mersey Area Prescribing Committee recommends the prescribing of TIOTROPIUM inhaler (Spiriva® Respimat®) as an option for patients with poorly controlled asthma who are already on a maintenance dose of inhaled corticosteroid plus a long-acting beta2 agonist inhaler.